BACTERIAL RESISTANCE TO CEFTRIAXONE IN DIFFERENT SPECIMENS AT GOVERNMENTAL HOSPITALS IN GAZA STRIP
DOI:
https://doi.org/10.37268/mjphm/vol.23/no.1/art.974Keywords:
Ceftriaxone, Escherichia coli, Klebsiella, Pseudomonas, Staphylococcus aureus, bacterial resistanceAbstract
Ceftriaxone is one of the most prescribed antibiotics in hospitalized patients in Gaza. This study aimed to screen the antimicrobial resistance profile of ceftriaxone in the Gaza Strip (GS) in the State of Palestine. This study was cross-sectional, hospital-based, and was conducted in governmental hospitals across GS. The study started in November 2017 and continued till December 2018. Clinical samples such as pus, urine, sputum, blood, cerebrospinal fluid (CSF), and others were collected from hospitalized patients and outpatient clinics attendants. After identification of the bacterial isolates, a standard disc diffusion technique for drug susceptibility test was performed. Totally, 4397 bacterial isolates were obtained. Escherichia coli isolates were 38.3%, Klebsiella species were 16.4%, Pseudomonas species were 11.7%, and Staphylococcus aureus isolates were 11.5%. These mentioned organisms were the predominant organisms isolated from the study subjects. Additionally, 51.1% of the clinical isolates were found to be resistant to ceftriaxone. Also, 4.9% and 44.0% of the isolates remain intermediate and susceptible to ceftriaxone. E coli showed 50.0% (841/1683) resistance, while Klebsiella species showed 69.7% (502/720) resistance. Pseudomonas species showed 57.0% (294/516) resistance and S aureus showed 37.8% (191/505) resistance to ceftriaxone. Acinetobacter species showed 87.3% (96/110) resistance. Clinical isolates showed differences in their resistance to ceftriaxone during the study period, in different age categories, genders, and specimen types. The present study demonstrated an increase in the microbial resistance to ceftriaxone. It is very important to establish efficient strategies, updated prescribing guidelines and stewardship programs to preserve the efficiency of the antibiotics
References
Gootz TD. Discovery and development of new antimicrobial agents. Clinical microbiology reviews 1990; 3(1): 13-31.
WHO. The Selection and Use of Essential Medicines: Report of the WHO Expert Committee, 2015 (including the 19th WHO Model List of Essential Medicines and the 5th WHO Model List of Essential Medicines for Children): World Health Organization; 2015.
Stamm WE, Hooton TM. Management of urinary tract infections in adults. New England journal of medicine 1993; 329(18): 1328-34.
Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012; 54(8): e72-e112.
Coiffier G, Albert JD. Is ceftriaxone 2 g once daily a valid treatment option for osteoarticular infections due to Staphylococcus spp., Streptococcus spp., and Gram-negative rods? Joint, bone, spine : revue du rhumatisme 2014; 81(3): 200-2.
Brouwer MC, Tunkel AR, McKhann GM, 2nd, van de Beek D. Brain abscess. The New England journal of medicine 2014; 371(5): 447-56.
Sileshi A, Tenna A, Feyissa M, Shibeshi W. Evaluation of ceftriaxone utilization in medical and emergency wards of Tikur Anbessa specialized hospital: a prospective cross-sectional study. BMC pharmacology & toxicology 2016; 17: 7.
Beskid G, Christenson J, Cleeland R, DeLorenzo W, Trown P. In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin. Antimicrobial agents and chemotherapy 1981; 20(2): 159-67.
Richards DM, Heel RC, Brogden RN, Speight TM, Avery GS. Ceftriaxone. Drugs 1984; 27(6): 469-527.
Tomberg J, Unemo M, Davies C, Nicholas RA. Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry 2010; 49(37): 8062-70.
Lee H, Jung D, Yeom JS, et al. Evaluation of ceftriaxone utilization at multicenter study. The Korean journal of internal medicine 2009; 24(4): 374-80.
Pinto Pereira LM, Phillips M, Ramlal H, Teemul K, Prabhakar P. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy. BMC infectious diseases 2004; 4(1): 59.
Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. International journal of medical microbiology 2010; 300(6): 371-9.
Noor R, Munna MS. Emerging diseases in Bangladesh: current microbiological research perspective. Tzu Chi Medical Journal 2015; 27(2): 49-53.
Wong CKM, Kung K, Au-Doung PLW, et al. Antibiotic resistance rates and physician antibiotic prescription patterns of uncomplicated urinary tract infections in southern Chinese primary care. PloS one 2017; 12(5): e0177266.
Walker RD. Antimicrobial susceptibility testing methods and interpretation of results. Antimicrobial therapy in veterinary medicine 2006: 11-24.
McLaughlin HP, Sue D. Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening. BMC microbiology 2018; 18(1): 218-.
Karam G, Chastre J, Wilcox MH, Vincent J-L. Antibiotic strategies in the era of multidrug resistance. Critical Care 2016; 20(1): 136.
CLSI:, Clinical, Laboratory Standards I. Performance standards for antimicrobial susceptibility testing; 2017.
Samanipour A, Dashti-Khavidaki S, Abbasi M-R, Abdollahi A. Antibiotic resistance patterns of microorganisms isolated from nephrology and kidney transplant wards of a referral academic hospital. Journal of Research in Pharmacy Practice 2016; 5(1): 43-51.
Masood SH, Aslam N. In Vitro Susceptibility Test of Different Clinical Isolates against Ceftriaxone. Oman medical journal 2010; 25(3): 199-202.
Siddiqui B, Azmat R, Tikmani SS, et al. Frequency of bloodstream infection in febrile neutropenic patients, experience from a developing country. Annals of medicine and surgery (2012) 2018; 34: 71-4.
Fasugba O, Mitchell BG, Mnatzaganian G, Das A, Collignon P, Gardner A. Five-year antimicrobial resistance patterns of urinary Escherichia coli at an Australian tertiary hospital: time series analyses of prevalence data. PloS one 2016; 11(10): e0164306.
Ramsey EG, Royer J, Bookstaver PB, et al. Seasonal Variation in Antimicrobial Resistance Rates of Community-Acquired Escherichia coli Bloodstream Isolates. International Journal of Antimicrobial Agents 2019.
Chua KY, Stewardson AJ. Individual and community predictors of urinary ceftriaxone-resistant Escherichia coli isolates, Victoria, Australia. Antimicrobial Resistance & Infection Control 2019; 8(1): 36.
Hay SI, Rao PC, Dolecek C, et al. Measuring and mapping the global burden of antimicrobial resistance. BMC medicine 2018; 16(1): 78.
Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet Infectious Diseases 2018; 18(3): 318-27.
Polse R, Yousif S, Assafi M. Prevalence and antimicrobial susceptibility patterns of uropathogenic E. coli among people in Zakho, Iraq. International Journal of Research in Medical Sciences 2016; 4(4): 1219-23.
Abdulrahman IS. Antimicrobial Susceptibility Pattern of Pathogenic Bacteria Causing Urinary Tract Infections at Azadi Hospital In Duhok CityKurdistan Region of Iraq. Science Journal of University of Zakho 2018; 6(2): 46-50.
Sabir S, Anjum AA, Ijaz T, Ali MA. Isolation and antibiotic susceptibility of E. coli from urinary tract infections in a tertiary care hospital. Pakistan journal of medical sciences 2014; 30(2): 389.
Gashe F, Mulisa E, Mekonnen M, Zeleke G. Antimicrobial resistance profile of different clinical isolates against third-generation cephalosporins. Journal of pharmaceutics 2018; 2018.
Asensio A, Alvarez-Espejo T, Fernandez-Crehuet J, et al. Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010. Euro surveillance 2011.
Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infectious disease clinics of North America 1997; 11(3): 551-81.
El-Astal Z. Bacterial pathogens and their antimicrobial susceptibility in Gaza Strip, Palestine. Pak J Med Sci 2004; 20(4): 365-70.
Al Laham NA. Distribution and antimicrobial resistance pattern of bacteria isolated from operation theaters at Gaza strip. Journal of Al Azhar University-Gaza (Natural Sciences) 2012; 14(1): 19-34.
Seifert H, Baginski R, Schulze A, Pulverer G. Antimicrobial susceptibility of Acinetobacter species. Antimicrobial agents and chemotherapy 1993; 37(4): 750-3.
Elbadawi HS, Elhag KM, Mahgoub E, Altayb HN, Hamid MMA. Antimicrobial resistance surveillance among gram-negative bacterial isolates from patients in hospitals in Khartoum State, Sudan. F1000Research 2019; 8.
MKK F, Rashid SS, MHM N, Baharudin R, Ramli ANM. A clinical update on Antibiotic Resistance Gram-negative bacteria in Malaysia-a review. arXiv preprint arXiv:190303486 2019.
Elmanama AA. Antimicrobial Resistance of Acinetobacter spp. Isolated from Pus Specimens from AL-Shifa Hospital, Gaza, Palestine. Antimicrobial Resistance of Acinetobacter spp Isolated from Pus Specimens from AL-Shifa Hospital, Gaza, Palestine 2006; 10.
Hudson CM, Bent ZW, Meagher RJ, Williams KP. Resistance determinants and mobile genetic elements of an NDM-1-encoding Klebsiella pneumoniae strain. PloS one 2014; 9(6): e99209-e.
Krishnamurthy V, G S V, Kumar M S, H V P, R P, E R N. Phenotypic and Genotypic Methods for Detection of Extended Spectrum β Lactamase Producing Escherichia coli and Klebsiella pneumoniae Isolated from Ventilator Associated Pneumonia. Journal of clinical and diagnostic research : JCDR 2013; 7(9): 1975-8.
Xu H, Huo C, Sun Y, et al. Emergence and molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates harboring bla (CTX-M-15) extended-spectrum β-lactamases causing ventilator-associated pneumonia in China. Infection and drug resistance 2018; 12: 33-43.
Juan C-H, Chuang C, Chen C-H, Li L, Lin Y-T. Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial Klebsiella pneumoniae bacteremia. Antimicrobial Resistance & Infection Control 2019; 8(1): 1.
Wang C, Yuan Z, Huang W, Yan L, Tang J, Liu C-W. Epidemiologic analysis and control strategy of Klebsiella pneumoniae infection in intensive care units in a teaching hospital of People's Republic of China. Infection and drug resistance 2019; 12: 391-8.
Jefferies J, Cooper T, Yam T, Clarke S. Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit–a systematic review of risk factors and environmental sources. Journal of medical microbiology 2012; 61(8): 1052-61.
Huddleston JR, Zak JC, Jeter RM. Antimicrobial susceptibilities of Aeromonas spp. isolated from environmental sources. Appl Environ Microbiol 2006; 72(11): 7036-42.
Amini A, Namvar AE. Antimicrobial Resistance Pattern and Presence of Beta-Lactamase Genes in Pseudomonas aeruginosa Strains Isolated from Hospitalized Patients, Babol-Iran. Journal of Medical Bacteriology 2019; 8(1, 2)): 45-50.
Shoaib MH, Naqvi SBS, Sheikh D, HASHMI HK. Cephalosporin resistance and β-lactamase production in clinical isolates of staphylococcus aureus in Karachi. Pakistan journal of pharmaceutical sciences 2001; 14(2): 23-32.
Nimer NA, Dayem SAA, AbouNouar GAK, Dakkah ANH. Evaluating Antibiotic Sensitivity Patterns of Pseudomonas in Relation to Specimen Type in Jordanian Hospital. JPMA 2019.
